• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Ambulatory diagnosis and therapy control of portasystemic encephalopathy in patients with liver cirrhosis].

作者信息

Rink C, Mantel E, Haerting J, Nilius R

出版信息

Dtsch Z Verdau Stoffwechselkr. 1985;45(6):295-301.

PMID:4092654
Abstract

The Number Connection Test (NCT) by Harold O. Conn was tested for its usefulness for diagnosis and treatment control of portasystemic encephalopathy in out-patients. For this purpose in 30 patients with liver cirrhosis the time in the NCT was determined and the serum ammonia level (NH3) was measured before the treatment with lactulose and neomycin was started. Moreover, 12 clinical symptoms and 10 laboratory parameters were tested for correlation with the NCT-time. We found a positive correlation between the NCT-time and NH3 serum level. For the prediction of the NCT-time the multiple linear regression yielded the combination of NH3 with the proof of ascites and palmar erythema as the best subset of predictor variables. By means of the NCT the effectiveness of the treatment with lactulose and neomycin was demonstrated. We recommend the NCT for the clinical routine in particular for the early diagnosis and for treatment control of portasystemic encephalopathy in patients with liver cirrhosis.

摘要

相似文献

1
[Ambulatory diagnosis and therapy control of portasystemic encephalopathy in patients with liver cirrhosis].
Dtsch Z Verdau Stoffwechselkr. 1985;45(6):295-301.
2
Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice.普通实践中未选择的肝硬化患者群体中潜在门体性脑病的患病率。
Z Gastroenterol. 1993 Apr;31(4):231-4.
3
[Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].[慢性肝病。肝性脑病是否经常被忽视?]
MMW Fortschr Med. 2000 Jun 22;142(25):56-7.
4
Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.L-鸟氨酸-L-天冬氨酸输注对肝硬化和肝性脑病患者的治疗效果:一项安慰剂对照双盲研究的结果
Hepatology. 1997 Jun;25(6):1351-60. doi: 10.1002/hep.510250609.
5
Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.肝硬化患者显性肝性脑病的一级预防:乳果糖与无乳果糖的开放性标签随机对照试验。
J Gastroenterol Hepatol. 2012 Aug;27(8):1329-35. doi: 10.1111/j.1440-1746.2012.07186.x.
6
Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.乳果糖治疗前后肝硬化合并轻微肝性脑病患者的睡眠障碍
Metab Brain Dis. 2017 Apr;32(2):595-605. doi: 10.1007/s11011-016-9944-5. Epub 2017 Jan 9.
7
Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.乳果糖治疗肝外门静脉阻塞患者的轻微型肝性脑病。
Saudi J Gastroenterol. 2012 May-Jun;18(3):168-72. doi: 10.4103/1319-3767.96448.
8
[Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial].
Gastroenterol Clin Biol. 1994;18(12):1063-8.
9
Hepatic encephalopathy: pathophysiology and emerging therapies.肝性脑病:病理生理学与新兴疗法
Med Clin North Am. 2009 Jul;93(4):819-36, vii. doi: 10.1016/j.mcna.2009.03.009.
10
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.新霉素-山梨醇和乳果糖治疗急性门体性脑病:一项对照双盲临床试验
Am J Dig Dis. 1978 May;23(5):398-406. doi: 10.1007/BF01072921.